ATOS
Atossa Therapeutics Inc
-7.00%
$0.77 - $0.72
Feb 8th 2023 - Mar 22nd 2023
Mar, 10, 2023
$ATOS Dr Quay is on the right path, after seeing t... See more
Mar, 7, 2023
Given what I've seen with a few other cancer d... See more
GTHX
G1 Therapeutics Inc
-59.51%
$7.78 - $3.15
Feb 7th 2023 - Mar 21st 2023
Feb, 15, 2023
Cosela was very effective versus myelosuppression ... See more
Jan, 12, 2023
$GTHX this is my favorite Cancer Biotech Company.
No reviews available.
Mar, 10, 2023
$ATOS Dr Quay is on the right path, after seeing the FDA’s mammogram and breast density article.
Mar, 7, 2023
Given what I've seen with a few other cancer drugs, I think it's reasonable and may offer other upgrades to my PT.
Jan, 31, 2023
They save Breasts too! 🥂🥂🥂
Jan, 26, 2023
$ATOS good strategic position: out from covid and focus on cancer
Dec, 19, 2022
at Mayo Clinic and Director of the Mayo Clinic Breast Cancer SPORE, as the lead principal investigator for this multi-center study" That's a really good lineup.
Nov, 26, 2022
CRISPR vs breast, colon, lung cancer: First human trial goes well https://www.medicalnewstoday.com/articles/cancer-single-step-crispr-treatment-may-provide-lifelong-protection
Nov, 23, 2022
Hoping for Atossa to save those fabulous breasts! 🙏🙏🙏
Oct, 25, 2022
$ATOS Ditching Covid-19 program to refocus back on breast cancer, nice. 👍👍💎🤲💎
Feb, 15, 2023
Cosela was very effective versus myelosuppression in both lung cancer & colon cancer trials.
Jan, 12, 2023
$GTHX this is my favorite Cancer Biotech Company.
Jan, 11, 2023
The duration of the therapy would expand from 3 months to 6 to 12 months: 100% to 300% increase The results would also be that the overall costs would sink and that it would attract more investors or other biotechs..
Dec, 25, 2022
$GTHX - $20-30 EOY, bladder cancer results next week, CRC in Q1, and Cosela is just a great/life saving drug overall.
Dec, 8, 2022
This all bodes well towards making the drug cancer a available to all cancer patients!
Nov, 10, 2022
$GTHX glad I got another chunk yesterday - I’m ride or die in this … Cosela works and will be approved for CRC, will be approved for TNBC and Bladder.
Nov, 4, 2022
$GTHX good earnings, 1st phase 2 is a win, next phase 2 result in less than 1 month at the San Antonio Breast Cancer Symposium 06-10 December 2022 and the third one via press release as per Jack Bailey
Oct, 18, 2022
If people can complete their chemo with Cosela, it automatically beats everything else in the sector.